TCXB

10.2901.06%
JB

Joshua B. Cohen

Independent Director

Mr. Joshua B. Cohen, also known as Josh, is Independent Director of TCGX Acquisition Corp. II from October 15, 2026. He co-founded Amylyx Pharmaceuticals, Inc. in 2013 and has been its Co-Chief Executive Officer and Director since January 2014. Mr. Cohen served as Chairman of the Board and Treasurer at Amylyx Pharmaceuticals, Inc. Mr. Cohen has helped build Amylyx from an idea into a rigorous company poised to enter clinical testing. His research expertise includes work both at Brown University and at the National Institute of Standards in Technology. He received his BS in biomedical engineering from Brown University.

Positions